Jackson, MS - Nearly 85 million U.S. citizens have hypertension (high blood pressure). A normal blood pressure reading is 120 over 80, but high blood pressure (as a result of diet, lifestyle choices and stress) is higher than 140 over 90. Left untreated, hypertension can lead to cardiovascular problems. Dr. Nishant Rao, medical director at Diet Doc medical weight loss has lead his team to search for safe ways to effectively treat hypertension. “Millions of Americans use Atenolol for hypertension, a medication that works well and has minimal side effects.” He continued, “The supply of this medication has suddenly decreased, leading many to try different medications with more side effects, or implement lifestyle changes to decrease the need and dependency for the medications.”
|
|||
The good news, is that numerous clinical trials have shown that as little as a 5-10 percent reduction in body weight can dramatically improve metabolic syndrome, type II diabetes and hypertension. Many people don’t realize how little weight loss it takes to make a dramatic improvement in hypertension and then have the ability to use less drug intervention. Patients faced with the atenolol shortage can use this crossroads to lose fat efficiency, rapidly and directly improve outcomes for chronic disease. Diet Doc has created medically supervised programs which are free from all stimulants that cause hypertension, such as the commonly prescribed phentermine and other weight loss pills which are central nervous system stimulants. “For an average patient weighing 180 lbs., this equates to a 9-18 lbs. weight loss to improve long term health outcomes,” says Dr. Rao. This can be accomplished with rapid, medically supervised weight loss programs without the use of any stimulants. Diet Doc offers such programs via convenient, telemedicine-based doctor consultations and home shipments of safe weight loss medications that suppress appetite, control unhealthy eating habits and promote fast fat burning and regulate blood pressure levels.
With a team of doctors, nurses, nutritionists and motivational coaches, Diet Doc products help individuals lose weight fast and keep it off. Patients can get started immediately, with materials shipped directly to their home or office. They can also maintain weight loss in the long-term through weekly consultations, customized diet plans, motivational coaches and a powerful prescription program. With Diet Doc, the doctor is only a short phone call away and a fully dedicated team of qualified professionals is available 6 days per week to answer questions, address concerns and support patients.
Getting started with Diet Doc is very simple and affordable. New patients can easily visit https://www.dietdoc.com to quickly complete a health questionnaire and schedule an immediate, free online consultation.
About the Company:
Diet Doc Weight Loss is the nation's leader in medical, weight loss offering a full line of prescription medication, doctor, nurse and nutritional coaching support. For over a decade, Diet Doc has produced a sophisticated, doctor designed weight loss program that addresses each individual specific health need to promote fast, safe and long term weight loss.
Twitter: https://twitter.com/DietDocMedical
Facebook: https://www.facebook.com/DietDocMedicalWeightLoss/
LinkedIn: https://www.LinkedIn.com/company/diet-doc-weight-loss?trk=biz-brand-tree-co-logo
CONTACT INFORMATION
Diet Doc Contact Information:
Providing care across the USA
Headquarters:
San Diego, CA
800-311-5610
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/5417d4a6-d417-420a-9968-c800dabbbae2
Julie Wright Diet Doc 800-311-5610 [email protected]


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Instagram Outage Disrupts Thousands of U.S. Users
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



